KELLEY SCOTT 4
4 · Flexion Therapeutics Inc · Filed Mar 5, 2019
Insider Transaction Report
Form 4
KELLEY SCOTT
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2019-03-01+18,000→ 18,000 totalExercise: $14.75Exp: 2029-02-28→ Common Stock (18,000 underlying) - Award
Common Stock
2019-03-01+36,000→ 51,271 total
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest one year after January 1, 2019 (the "Vesting Commencement Date") and thereafter one-forty-eighth (1/48th) of the total shares shall vest each month following the one year anniversary of the Vesting Commencement Date, so that all of the shares shall be vested four (4) years after the Vesting Commencement Date.